flucytosine has been researched along with Primary Peritonitis in 35 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B and oral flucytosine for 5 weeks." | 7.69 | Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995) |
| "This report describes two cases of peritoneal dialysis-related peritonitis caused by Fusarium species which have been incriminated in a variety of disease conditions." | 7.68 | Fusarium peritonitis in peritoneal dialysis: report of two cases. ( Chiaradia, V; Pascoli, L; Santini, GF; Schinella, D; Tesio, F, 1990) |
| "Five episodes of fungal peritonitis were treated by intraperitoneal instillation of 5-flucytosine (5-Fc) while the patients remained on their usual schedule of dialysis." | 7.67 | Intraperitoneal flucytosine in the management of fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. ( Eisenberg, ES, 1988) |
| "A case of Candida albicans peritonitis in a CAPD patient successfully treated with Flucytosine is reported." | 7.66 | Management of candida peritonitis in a CAPD patient by flucytosine therapy: importance of drug level monitoring in body fluids. ( Giangrande, A; Limido, A; Tortorano, AM; Viviani, MA, 1983) |
| "Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B and oral flucytosine for 5 weeks." | 3.69 | Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995) |
| "Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B 1-2 mg and oral flucytosine or fluconazole 50 mg b." | 3.69 | Successful treatment of fungal peritonitis with intracatheter antifungal retention. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995) |
| "This report describes two cases of peritoneal dialysis-related peritonitis caused by Fusarium species which have been incriminated in a variety of disease conditions." | 3.68 | Fusarium peritonitis in peritoneal dialysis: report of two cases. ( Chiaradia, V; Pascoli, L; Santini, GF; Schinella, D; Tesio, F, 1990) |
| "A case of candida peritonitis during continuous ambulatory peritoneal dialysis (CAPD) which recovered with intraperitoneal 5-fluorocytosine alone is reported." | 3.67 | Successful in situ treatment of a fungal peritonitis during CAPD. ( Benarbia, S; Brocard, JF; Charpentier, B; Fries, D; Hammouche, M; Pocheville, M, 1984) |
| "Five episodes of fungal peritonitis were treated by intraperitoneal instillation of 5-flucytosine (5-Fc) while the patients remained on their usual schedule of dialysis." | 3.67 | Intraperitoneal flucytosine in the management of fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. ( Eisenberg, ES, 1988) |
| "A case of Candida albicans peritonitis in a CAPD patient successfully treated with Flucytosine is reported." | 3.66 | Management of candida peritonitis in a CAPD patient by flucytosine therapy: importance of drug level monitoring in body fluids. ( Giangrande, A; Limido, A; Tortorano, AM; Viviani, MA, 1983) |
| "Fungal peritonitis is a rare cause of peritonitis, but it is associated to poorer prognosis and higher mortality than bacterial peritonitis." | 1.33 | [Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases]. ( Aparicio, M; García Ramón, R; Miguel, A; Molina, P; Puchades, MJ, 2005) |
| " In conclusion, from a pharmacokinetic point of view, all the antifungal agents examined, perhaps with the exception of F, do not offer, when used alone, sufficient guarantees in curing peritonitis." | 1.29 | Pharmacokinetics of antifungal agents. ( Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV, 1993) |
| " Although appropriate therapy of fungal peritonitis in patients undergoing CAPD still remains controversial, both for the drug of choice and for the dosage to be used, our study indicates that a 5-week course of oral 5-fluorocytosine (5-FC) may obviate the need to remove the peritoneal catheter during the management of peritonitis caused by susceptible strains of T glabrata." | 1.27 | Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine. ( Cecchin, E; Chiaradia, V; De Marchi, S; Franceschin, A; Panarello, G; Santini, G; Tesio, F, 1984) |
| "Peritonitis was usually treated with intraperitoneal administration of cefazolin sodium, and 61% of the episodes were treated at home." | 1.27 | Peritonitis in children undergoing continuous ambulatory peritoneal dialysis. ( Calvin, S; Luis, ES; McDaid, T; Potter, D; Powell, D, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (60.00) | 18.7374 |
| 1990's | 10 (28.57) | 18.2507 |
| 2000's | 4 (11.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez Melón, C | 1 |
| Conde Rivera, O | 1 |
| Novoa Fernández, E | 1 |
| Borrajo Prol, M | 1 |
| Molina, P | 1 |
| Puchades, MJ | 1 |
| Aparicio, M | 1 |
| García Ramón, R | 1 |
| Miguel, A | 1 |
| Freydiere, AM | 1 |
| Piens, MA | 1 |
| Andre, JM | 1 |
| Putet, G | 1 |
| Picot, S | 1 |
| van der Voort, PH | 1 |
| Boerma, EC | 1 |
| Yska, JP | 1 |
| Cecchin, E | 3 |
| Panarello, G | 3 |
| De Marchi, S | 3 |
| Franceschin, A | 1 |
| Chiaradia, V | 2 |
| Santini, G | 1 |
| Tesio, F | 3 |
| Pomeranz, A | 1 |
| Reichenberg, Y | 1 |
| Mor, J | 1 |
| Drukker, A | 1 |
| Giangrande, A | 1 |
| Tortorano, AM | 1 |
| Limido, A | 1 |
| Viviani, MA | 1 |
| Pocheville, M | 1 |
| Charpentier, B | 1 |
| Brocard, JF | 1 |
| Benarbia, S | 1 |
| Hammouche, M | 1 |
| Fries, D | 1 |
| Lempert, KD | 1 |
| Jones, JM | 1 |
| Bruu, AL | 1 |
| Melby, K | 1 |
| Midvedt, T | 1 |
| Smith-Reichsen, N | 1 |
| Lee, SH | 2 |
| Chiang, SS | 2 |
| Hseih, SJ | 2 |
| Shen, HM | 2 |
| Amici, G | 1 |
| Grandesso, S | 1 |
| Mottola, A | 1 |
| Virga, G | 1 |
| Teodori, T | 1 |
| Maresca, MC | 1 |
| Bocci, C | 1 |
| Michel, C | 1 |
| Courdavault, L | 1 |
| al Khayat, R | 1 |
| Viron, B | 1 |
| Roux, P | 1 |
| Mignon, F | 1 |
| Fabris, A | 1 |
| Pellanda, MV | 1 |
| Gardin, C | 1 |
| Contestabile, A | 1 |
| Bolzonella, R | 1 |
| Finazzi, R | 1 |
| Guffanti, M | 1 |
| Cernuschi, M | 1 |
| Erembourg, L | 1 |
| Capasso, G | 1 |
| Ossi, C | 1 |
| Gesu, G | 1 |
| Guiserix, J | 1 |
| Ramdane, M | 1 |
| Finielz, P | 1 |
| Michault, A | 1 |
| Rajaonarivelo, P | 1 |
| Andersen, KE | 1 |
| Olsen, H | 1 |
| Muther, RS | 1 |
| Bennett, WM | 1 |
| Holdsworth, SR | 1 |
| Atkins, RC | 1 |
| Scott, DF | 1 |
| Jackson, R | 1 |
| Gibb, AP | 1 |
| Aggarwal, R | 1 |
| Swainson, CP | 1 |
| Schinella, D | 1 |
| Pascoli, L | 1 |
| Santini, GF | 1 |
| Nielsen, H | 1 |
| Stenderup, J | 1 |
| Bruun, B | 1 |
| Ladefoged, J | 1 |
| Guarner, J | 1 |
| Del Rio, C | 1 |
| Williams, P | 1 |
| McGowan, JE | 1 |
| Mocan, H | 1 |
| Murphy, AV | 1 |
| Beattie, TJ | 1 |
| McAllister, TA | 1 |
| Struijk, DG | 2 |
| Krediet, RT | 2 |
| Boeschoten, EW | 2 |
| Rietra, PJ | 2 |
| Arisz, L | 2 |
| Eisenberg, ES | 1 |
| Tapson, JS | 1 |
| Mansy, H | 1 |
| Freeman, R | 1 |
| Wilkinson, R | 1 |
| Edwards, R | 1 |
| Birrell, LN | 1 |
| Finch, RG | 1 |
| Powell, D | 1 |
| Luis, ES | 1 |
| Calvin, S | 1 |
| McDaid, T | 1 |
| Potter, D | 1 |
| Johnson, RJ | 1 |
| Ramsey, PG | 1 |
| Gallagher, N | 1 |
| Ahmad, S | 1 |
| Benevent, D | 1 |
| Peyronnet, P | 1 |
| Lagarde, C | 1 |
| Leroux-Robert, C | 1 |
2 reviews available for flucytosine and Primary Peritonitis
| Article | Year |
|---|---|
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administ | 1994 |
Fungal peritonitis caused by Curvularia lunata in a patient undergoing peritoneal dialysis.
Topics: Bacterial Infections; Catheters, Indwelling; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fung | 1989 |
33 other studies available for flucytosine and Primary Peritonitis
| Article | Year |
|---|---|
[Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheter-Related Infections; Device Rem | 2009 |
[Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Ca | 2005 |
Successful treatment of Candida glabrata peritonitis with fluconazole plus flucytosine in a premature infant following in vitro fertilization.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Therapy, Combination; Fertilization in Vitro; | 2005 |
Serum and intraperitoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis.
Topics: Aged; Amphotericin B; Ascitic Fluid; Candidiasis; Critical Care; Female; Flucytosine; Fungemia; Huma | 2007 |
Fungal peritonitis in ambulatory peritoneal dialysis.
Topics: Candida; Candidiasis; Flucytosine; Humans; Mycoses; Peritoneal Dialysis; Peritoneal Dialysis, Contin | 1984 |
Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine.
Topics: Aged; Candida; Female; Flucytosine; Humans; Male; Mycoses; Peritoneal Dialysis; Peritoneal Dialysis, | 1984 |
Candida peritonitis-inefficacy of amphotericin-B and 5-fluorocytosine treatment.
Topics: Amphotericin B; Candidiasis; Catheters, Indwelling; Child, Preschool; Cytosine; Drug Therapy, Combin | 1983 |
Management of candida peritonitis in a CAPD patient by flucytosine therapy: importance of drug level monitoring in body fluids.
Topics: Body Fluids; Candidiasis; Cytosine; Flucytosine; Humans; Male; Middle Aged; Peritoneal Dialysis; Per | 1983 |
Successful in situ treatment of a fungal peritonitis during CAPD.
Topics: Adult; Candidiasis; Cytosine; Female; Flucytosine; Humans; Peritoneal Dialysis; Peritoneal Dialysis, | 1984 |
Flucytosine-miconazole treatment of Candida peritonitis. Its use during continuous ambulatory peritoneal dialysis.
Topics: Candidiasis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Humans; Imidazoles; Kidney Fa | 1982 |
[Candida albicans peritonitis treated with 5-fluorocytosine].
Topics: Aged; Candidiasis; Cytosine; Flucytosine; Humans; Male; Peritonitis | 1980 |
Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Fluc | 1995 |
Verticillium peritonitis in a patient on peritoneal dialysis.
Topics: Adult; Fluconazole; Flucytosine; Humans; Male; Mitosporic Fungi; Mycoses; Peritoneal Dialysis, Conti | 1994 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritone | 1993 |
Successful treatment of fungal peritonitis with intracatheter antifungal retention.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Flucytos | 1995 |
Unusual presentation of cryptococcosis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; An | 1996 |
Trichoderma harzianum peritonitis in peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Bacterial Infections; Diabetes Mellitus, Type 2; Diabeti | 1996 |
Candida peritonitis in a patient receiving chronic intermittent peritoneal dialysis.
Topics: Candida albicans; Candidiasis; Female; Flucytosine; Humans; Middle Aged; Peritoneal Dialysis; Perito | 1978 |
Clearance of amphotericin B and 5-fluorocytosine by peritoneal dialysis.
Topics: Amphotericin B; Ascitic Fluid; Cryptococcus; Cytosine; Flucytosine; Humans; Kidney Failure, Chronic; | 1979 |
Management of Candida peritonitis by prolonged peritoneal lavage containing 5-fluorocytosine.
Topics: Candidiasis; Cytosine; Female; Flucytosine; Half-Life; Humans; Middle Aged; Peritoneal Dialysis; Per | 1975 |
Successful treatment of Prototheca peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Diabetes Mellitus, Type 1; Fluconazole; Flucytosine; Humans; Infections; Male; Middl | 1991 |
Fusarium peritonitis in peritoneal dialysis: report of two cases.
Topics: Aged; Catheters, Indwelling; Female; Flucytosine; Fusarium; Humans; Male; Mycoses; Peritoneal Dialys | 1990 |
Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis.
Topics: Adult; Amphotericin B; Blood; Candida; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; | 1990 |
Fungal peritonitis in children on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Amphotericin B; Candidiasis; Child; Child, Preschool; Cryptococcosis; Female; Flucytosin | 1989 |
Antifungal treatment of Candida peritonitis in CAPD patients.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Peritoneal Dialysis, Continuous Ambulatory; Perito | 1987 |
Intraperitoneal flucytosine in the management of fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Candidiasis; Flucytosine; Humans; Instillation, Drug; Peritoneal Cavity; Peritoneal Dialysis, Contin | 1988 |
The high morbidity of CAPD fungal peritonitis--description of 10 cases and review of treatment strategies.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Female; Flucytosine; Humans; Kidney Failure, Chr | 1986 |
Antifungal treatment of Candida peritonitis in continuous ambulatory peritoneal dialysis patients.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Therapy, Combination; Fe | 1987 |
In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Evaluation; Flucytosine; Human | 1987 |
Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Cefazolin; Child; Child, Preschool; Drug T | 1985 |
Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine; | 1985 |
Chemotherapy and/or removal of the peritoneal catheter in the management of fungal peritonitis complicating CAPD?
Topics: Candida; Catheters, Indwelling; Flucytosine; Humans; Mycoses; Peritoneal Dialysis; Peritoneal Dialys | 1985 |
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Three recoveries in 5 cases without catheter removal.
Topics: Adult; Aged; Amphotericin B; Catheterization; Drug Therapy, Combination; Female; Flucytosine; Humans | 1985 |